|
GSTCD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.9216899999952E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.8931000003244E-07 |
| Normal-vs-Stage2 |
1.425550E-02 |
| Normal-vs-Stage3 |
7.077300E-03 |
| Normal-vs-Stage4 |
1.686380E-02 |
| Stage1-vs-Stage2 |
2.709400E-01 |
| Stage1-vs-Stage3 |
3.250600E-01 |
| Stage1-vs-Stage4 |
6.782200E-01 |
| Stage2-vs-Stage3 |
8.687800E-01 |
| Stage2-vs-Stage4 |
7.661000E-01 |
| Stage3-vs-Stage4 |
8.593600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.78270000000303E-05 |
| Normal-vs-AfricanAmerican |
2.21389999999211E-05 |
| Normal-vs-Asian |
2.877200E-03 |
| Caucasian-vs-AfricanAmerican |
5.088000E-01 |
| Caucasian-vs-Asian |
4.623400E-01 |
| AfricanAmerican-vs-Asian |
5.918200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72929999986415E-07 |
| Normal-vs-Female |
1.010380E-02 |
| Male-vs-Female |
5.502200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.89980000000678E-05 |
| Normal-vs-Extreme_Weight |
3.21240000156209E-08 |
| Normal-vs-Obese |
2.604200E-03 |
| Normal-vs-Extreme_Obese |
1.722610E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.910000E-01 |
| Normal_Weight-vs-Obese |
1.375030E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.330000E-01 |
| Extreme_Weight-vs-Obese |
6.896300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.804600E-01 |
| Obese-vs-Extreme_Obese |
3.498000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.457800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.150850E-04 |
| Normal-vs-Age(61-80Yrs) |
1.60739999999215E-06 |
| Normal-vs-Age(81-100Yrs) |
1.84721999999526E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.708600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.213400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.913900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.230380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.061700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.600830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.55100000030085E-07 |
| Normal-VS-Type2 PRCC |
8.24280000000233E-05 |
| Normal-VS-KIRP CIMP |
9.316300E-02 |
| Normal-VS-Unclassified PRCC |
5.002300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.701000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.955400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.083700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.633600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.364980E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.583400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.20780000001375E-06 |
| Normal-vs-N1 |
7.674000E-02 |
| Normal-vs-N2 |
2.831400E-01 |
| N0-vs-N1 |
6.259600E-02 |
| N0-vs-N2 |
2.852200E-01 |
| N1-vs-N2 |
9.460400E-01 |
|
|
